UBS Group’s Lam Research LRCX Stock Holding History

UBS Group’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$49.6M	Sell	232,100 -87,900	-27%	-$19.7M	0.01%	1651
2025 Q4	$54.8M	Sell	320,000 -5,300	-2%	-$824K	0.01%	1519
2025 Q3	$43.6M	Buy	325,300 +183,500	+129%	+$19.4M	0.01%	1778
2025 Q2	$13.8M	Sell	141,800 -387,000	-73%	-$30.7M	﹤0.01%	2770
2025 Q1	$38.4M	Sell	528,800 -23,000	-4%	-$1.81M	0.01%	1715
2024 Q4	$39.9M	Sell	551,800 -27,200	-5%	-$2.06M	0.01%	1657
2024 Q3	$47.3M	Buy	579,000 +182,000	+46%	+$15.8M	0.01%	1181
2024 Q2	$42.3M	Sell	397,000 -24,000	-6%	-$2.3M	0.01%	1150
2024 Q1	$40.9M	Sell	421,000 -401,000	-49%	-$35.3M	0.01%	1167
2023 Q4	$64.4M	Buy	822,000 +92,000	+13%	+$6.27M	0.02%	821
2023 Q3	$45.8M	Hold	730,000	–	–	0.02%	917
2023 Q2	$46.9M	Sell	730,000 -1,034,000	-59%	-$58.3M	0.02%	868
2023 Q1	$93.5M	Sell	1,764,000 -1,537,000	-47%	-$75.4M	0.03%	484
2022 Q4	$139M	Buy	3,301,000 +312,000	+10%	+$13.1M	0.05%	372
2022 Q3	$109M	Buy	2,989,000 +638,810	+27%	+$28.4M	0.05%	401
2022 Q2	$100M	Buy	2,350,190 +892,190	+61%	+$42.5M	0.04%	444
2022 Q1	$78.4M	Buy	1,458,000 +64,000	+5%	+$3.73M	0.03%	613
2021 Q4	$100M	Buy	1,394,000 +975,000	+233%	+$61.1M	0.03%	599
2021 Q3	$23.8M	Buy	419,000 +230,000	+122%	+$14M	0.01%	1365
2021 Q2	$12.3M	Buy	189,000 +129,000	+215%	+$8.14M	﹤0.01%	1857
2021 Q1	$3.57M	Sell	60,000 -270,000	-82%	-$14.7M	﹤0.01%	2959
2020 Q4	$15.6M	Hold	330,000	–	–	0.01%	1514
2020 Q3	$10.9M	Buy	+330,000	New	+$11.4M	﹤0.01%	1581
2020 Q2	–	Sell	-129,000	Closed	-$3.1M	–	8176
2020 Q1	$3.1M	Sell	129,000 -76,000	-37%	-$2.19M	﹤0.01%	2354
2019 Q4	$5.99M	Buy	205,000 +123,000	+150%	+$3.27M	﹤0.01%	2441
2019 Q3	$1.9M	Buy	+82,000	New	+$1.72M	﹤0.01%	3340
2019 Q2	–	Sell	-5,000	Closed	-$90K	–	8028
2019 Q1	$90K	Buy	+5,000	New	+$83.4K	﹤0.01%	5141
2018 Q4	–	Sell	-24,000	Closed	-$364K	–	8182
2018 Q3	$364K	Sell	24,000 -626,000	-96%	-$10.7M	﹤0.01%	4631
2018 Q2	$11.2M	Buy	650,000 +500,000	+333%	+$9.63M	﹤0.01%	1636
2018 Q1	$3.05M	Sell	150,000 -250,000	-63%	-$4.95M	﹤0.01%	2753
2017 Q4	$7.36M	Buy	+400,000	New	+$7.86M	﹤0.01%	1988
2016 Q1	–	Sell	-9,000	Closed	-$71K	–	7934
2015 Q4	$71K	Hold	9,000	–	–	﹤0.01%	5515
2015 Q3	$59K	Sell	9,000 -474,000	-98%	-$3.47M	﹤0.01%	5683
2015 Q2	$3.93M	Buy	483,000 +474,000	+5,267%	+$3.72M	﹤0.01%	2322
2015 Q1	$63K	Sell	9,000 -28,000	-76%	-$221K	﹤0.01%	5832
2014 Q4	$294K	Buy	+37,000	New	+$287K	﹤0.01%	4676

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group's LRCX Position: Q1 2026 in Review

UBS Group reduced its Lam Research (LRCX) stake by 16% in Q1 2026, selling an estimated $281M and leaving 6,526,433 shares worth $1.39B. The position accounts for 0.21% of the portfolio, ranked #79.

UBS Group first reported a position in LRCX in Q4 2014 and has held it in 46 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

UBS Group held 6,526,433 shares of Lam Research worth $1.39B as of Q1 2026.
UBS Group sold 1,254,621 Lam Research shares in Q1 2026, an estimated $281M.
Lam Research made up 0.21% of UBS Group's portfolio in Q1 2026, its #79 holding.
UBS Group first reported a position in Lam Research in Q4 2014 and has held it in 46 quarters since.
2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.